Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 3:44 pm Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | ARMISTICE CAPITAL LLC | 2,207,070 3.880% | -1,316,930 (-37.37%) | View |
| 2024-11-08 2:40 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | Farallon Capital Partners L.P. | 5,660,866 9.900% | 1,493,264 (+35.83%) | View |
| 2024-02-14 2:21 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | ARMISTICE CAPITAL LLC | 3,524,000 6.310% | 774,000 (+28.15%) | View |
| 2024-02-14 2:06 pm Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | Rock Springs Capital Management LP | 2,152,173 3.850% | -844,419 (-28.18%) | View |
| 2024-02-13 06:07 am Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | BB BIOTECH AG | 4,000,000 7.200% | -30,792 (-0.76%) | View |
| 2024-02-12 11:21 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | VANGUARD GROUP INC | 5,599,917 10.020% | 72,479 (+1.31%) | View |
| 2024-02-12 10:50 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | VANGUARD GROUP INC | 5,527,438 9.890% | 192,362 (+3.61%) | View |
| 2024-02-08 11:39 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | Farallon Capital Partners L.P. | 4,167,602 7.500% | 206,000 (+5.20%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | BlackRock Inc. BLK | 4,962,237 8.900% | 193,363 (+4.05%) | View |
| 2024-01-22 12:37 pm Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | STATE STREET CORP STT | 2,625,685 4.700% | -553,383 (-17.41%) | View |
| 2023-11-09 5:18 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | Farallon Capital Partners L.P. | 3,961,602 7.100% | 3,961,602 (New Position) | View |
| 2023-11-09 1:26 pm Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | WELLINGTON MANAGEMENT GROUP LLP | 2,200,757 3.950% | -3,522,374 (-61.55%) | View |
| 2023-04-10 09:06 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | WELLINGTON MANAGEMENT GROUP LLP | 5,723,131 10.350% | 260,474 (+4.77%) | View |
| 2023-02-14 4:10 pm Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | BB BIOTECH AG | 4,030,792 7.300% | -281,500 (-6.53%) | View |
| 2023-02-14 2:50 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | Rock Springs Capital Management LP | 2,996,592 5.450% | 2,996,592 (New Position) | View |
| 2023-02-14 12:38 pm Sale | 13G | AGIOS PHARMACEUTICALS INC. AGIO | PRICE T ROWE ASSOCIATES INC | 1,480,194 2.700% | -1,398,520 (-48.58%) | View |
| 2023-02-14 11:54 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | ARMISTICE CAPITAL LLC | 2,750,000 5.010% | 2,750,000 (New Position) | View |
| 2023-02-09 10:54 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | VANGUARD GROUP INC | 5,335,076 9.710% | 266,486 (+5.26%) | View |
| 2023-02-08 09:25 am Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | STATE STREET CORP STT | 3,179,068 5.790% | 186,186 (+6.22%) | View |
| 2023-02-06 2:43 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC. AGIO | WELLINGTON MANAGEMENT GROUP LLP | 5,462,657 9.940% | 314,091 (+6.10%) | View |